Literature DB >> 6766423

Peptidergic (enkephalin) innervation of the mammalian esophagus.

R Uddman, J Alumets, R Håkanson, F Sundler, B Walles.   

Abstract

Enkephalin-like immunoreactivity was demonstrated in nerves in the esophagus of guinea-pig, opossum, cat, pig, monkey, and humans. Immunoreactive nerves were found in the external muscle layer and in the muscularis mucosae. In the myenteric plexus immunoreactive nerve fibers were numerous; immunoreactive nerve cell bodies were observed only occassionally. Enkephalin nerves appeared early (the 7th wk of gestation) in porcine fetuses; at this stage the nerves were confined to the myenteric plexus. Motor effects of enkephalin were studied on segments from circular smooth muscle of cat esophagus. Enkephalin inhibited electrically induced contractions in a dose-dependent manner. This effect was blocked by naloxone. The results suggest that enkephalin nerves may be involved in the regulation of esophageal motility. Like enkephalin, bretylium (a blocker of adrenergic transmission) and phentolamine (on alpha-adrenergic blocker) prevented the contractile response to electrical stimulation. With smooth muscle strips from reserpinized cats the response to electrical field stimulation was abolished, but not the response to norepinephrine. Taken together, the results suggest that neuronal enkephalin in the esophagus functions as a modulator of adrenergic transmission.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766423

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Intraluminal acid induces oesophageal shortening via capsaicin-sensitive neurokinin neurons.

Authors:  William G Paterson; David V Miller; Neil Dilworth; Joseph B Assini; Sandra Lourenssen; Michael G Blennerhassett
Journal:  Gut       Date:  2007-05-24       Impact factor: 23.059

2.  Ultrastructure and localization of substance P and met-enkephalin immunoreactivity in the human fetal gastric antrum.

Authors:  S E Kapadia; C R Kapadia
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

3.  Intramural distribution of immunoreactive vasoactive intestinal polypeptide (VIP), substance P, somatostatin and mammalian bombesin in the oesophago-gastro-pyloric region of the human gut.

Authors:  G L Ferri; T E Adrian; L Soimero; M Blank; D Cavalli; G Biliotti; J M Polak; S R Bloom
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

4.  Effect of methionine-enkephalin analog (FK 33-824) on plasma motilin.

Authors:  K Sekiya; A Funakoshi; I Nakano; H Nawata; K Kato; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1986-08

5.  Nerves containing substance P, vasoactive intestinal polypeptide, enkephalin or somatostatin in the guinea-pig taenia coli. Distribution, ultrastructure and possible functions.

Authors:  S Leander; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

6.  Modulation of post-prandial insulin release by ingested opiate-like substances in dogs.

Authors:  V Schusdziarra; A Holland; R Schick; A de la Fuente; M Klier; V Maier; V Brantl; E F Pfeiffer
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

7.  Enkephalin inhibits relaxation of the lower oesophageal sphincter.

Authors:  J M Howard; M R Belsheim; S N Sullivan
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

8.  Enkephalin-immunoreactive nerve fibers in the feline genito-urinary tract.

Authors:  P Alm; J Alumets; R Håkanson; C Owman; N O Sjöberg; M Stjernqvist; F Sundler
Journal:  Histochemistry       Date:  1981

9.  Influence of methionine-enkephalin analogue (FK-33-824) on the secretion of pancreatic hormones.

Authors:  K Sekiya; A Funakoshi; H Shinozaki; H Nawata; K Kato; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1985-06

10.  Influence of morphine on the distal oesophagus and the lower oesophageal sphincter--a manometric study.

Authors:  K Dowlatshahi; A Evander; B Walther; D B Skinner
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.